Background: Many enzymes of industrial interest are not in the market since they are bioproduced as bacterial inclusion bodies, believed to be biologically inert aggregates of insoluble protein.

Bacterial inclusion bodies are intriguing nanoparticulate materials produced by biological systems in inexpensive processes whose nanometer‐scale features can be finely tailored during biological production. This novel, mechanically stable, biocompatible nanomaterial is shown to be suitable for 2D cell growth engineering, among other potential biomedical applications.

No abstract

No abstract